Oncotelic Therapeutics, Inc.
OTLC
Revenue
70.00k
▼-1.33M▼-95.00%
39 Months ChangeAssets
29.94M
▼-39.24k▼-0.1309%
3 Months ChangeLiabilities
18.43M
▼-293.47k▼-1.57%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 10-Q
ID: 0001493152-24-031995
2024-05-15
Form 10-Q
ID: 0001493152-24-019332
2024-04-29
Form 8-K
ID: 0001493152-24-016839
2024-02-02
Form 8-K
ID: 0001493152-24-004783
2023-11-14
Form 10-Q
ID: 0001493152-23-040804
2023-10-30
Form 8-K
ID: 0001493152-23-038620
2023-08-23
Form 8-K
ID: 0001493152-23-029903
2023-08-18
Form 10-Q
ID: 0001493152-23-029461
2023-07-13
Form 8-K
ID: 0001493152-23-024401
2023-05-22
Form 10-Q
ID: 0001493152-23-018430